Kathy Q. Cai

6.2k total citations · 1 hit paper
117 papers, 3.7k citations indexed

About

Kathy Q. Cai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kathy Q. Cai has authored 117 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 37 papers in Oncology and 24 papers in Cancer Research. Recurrent topics in Kathy Q. Cai's work include RNA modifications and cancer (11 papers), Epigenetics and DNA Methylation (10 papers) and Cancer-related Molecular Pathways (9 papers). Kathy Q. Cai is often cited by papers focused on RNA modifications and cancer (11 papers), Epigenetics and DNA Methylation (10 papers) and Cancer-related Molecular Pathways (9 papers). Kathy Q. Cai collaborates with scholars based in United States, China and Japan. Kathy Q. Cai's co-authors include Andrew K. Godwin, Xiang‐Xi Xu, Callinice D. Capo‐chichi, Andres J. Klein–Szanto, Joseph R. Testa, Jinsong Liu, Dong‐Hua Yang, Elizabeth R. Smith, Gong Yang and Jennifer L. Smedberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Kathy Q. Cai

114 papers receiving 3.7k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ferroptotic cell death triggered by conjugated linolenic acids is mediated by ACSL1

2021 176 citations Kathy Q. Cai, Yinfei Tan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathy Q. Cai United States	34	2.2k	1.0k	940	936	387	117	3.7k
Zhenfeng Duan United States	37	1.7k 0.7×	1.3k 1.3×	952 1.0×	996 1.1×	176 0.5×	92	3.6k
Carmela Ricciardelli Australia	40	2.7k 1.2×	1.4k 1.3×	1.4k 1.4×	934 1.0×	1.1k 2.9×	104	4.9k
Viví Ann Flørenes Norway	42	3.5k 1.6×	2.2k 2.2×	1.0k 1.1×	780 0.8×	603 1.6×	108	5.4k
Dieter Niederacher Germany	38	2.4k 1.1×	1.6k 1.6×	1.4k 1.5×	408 0.4×	251 0.6×	143	4.2k
Frank Hilberg Austria	28	2.0k 0.9×	1.1k 1.1×	497 0.5×	1.2k 1.3×	286 0.7×	57	4.0k
Burkhard Helmke Germany	28	1.3k 0.6×	897 0.9×	484 0.5×	291 0.3×	254 0.7×	78	2.9k
Rosemary Foster United States	29	1.7k 0.8×	1.6k 1.5×	649 0.7×	197 0.2×	304 0.8×	46	3.1k
Hee Jung An South Korea	27	1.3k 0.6×	818 0.8×	766 0.8×	382 0.4×	111 0.3×	76	2.5k
Kazuhiro Sentani Japan	33	2.2k 1.0×	1.2k 1.1×	1.1k 1.2×	860 0.9×	329 0.9×	194	3.9k

Countries citing papers authored by Kathy Q. Cai

Since Specialization

Citations

This map shows the geographic impact of Kathy Q. Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Q. Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Q. Cai more than expected).

Fields of papers citing papers by Kathy Q. Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Q. Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Q. Cai. The network helps show where Kathy Q. Cai may publish in the future.

Co-authorship network of co-authors of Kathy Q. Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Q. Cai. A scholar is included among the top collaborators of Kathy Q. Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Q. Cai. Kathy Q. Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Ming, Janusz Franco‐Barraza, Kathy Q. Cai, et al.. (2024). A bioprinted sea-and-island multicellular model for dissecting human pancreatic tumor-stroma reciprocity and adaptive metabolism. Biomaterials. 310. 122631–122631. 8 indexed citations

Murayama, Takahiko, Navin R. Mahadevan, Catherine B. Meador, et al.. (2024). Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer. Cancer Research Communications. 4(9). 2399–2414. 10 indexed citations

Yang, Yijun, Qing Liu, Chakkapong Burudpakdee, et al.. (2024). Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells. Cancer Cell. 42(8). 1434–1449.e5. 8 indexed citations

Chen, Tao, Wenshuai Li, Yuan Shen, et al.. (2024). Encapsulation of individual mammalian cells as a cell-based drug delivery carrier for lung cancer treatment. Journal of Controlled Release. 378. 209–220.

Hooper, Robert, Dhanendra Tomar, Parkson Lee‐Gau Chong, et al.. (2022). Suppression of Ca ²⁺ signaling enhances melanoma progression. The EMBO Journal. 41(19). e110046–e110046. 12 indexed citations

Gong, Yulan, Maria F. Arisi, Lorenzo Gerratana, et al.. (2021). Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC). International Journal of Molecular Sciences. 22(16). 8924–8924. 1 indexed citations

Wang, Qinglin, Jian Hu, Haijuan Fu, et al.. (2021). Nestin Is Required for Spindle Assembly and Cell-Cycle Progression in Glioblastoma Cells. Molecular Cancer Research. 19(10). 1651–1665. 15 indexed citations

Kurimchak, Alison, Valerie L. Sodi, Nishi Srivastava, et al.. (2020). Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma. Science Signaling. 13(619). 19 indexed citations

Du, Fang, Eric H. Lee, Yuan Wang, et al.. (2019). Leukotriene Synthesis Is Critical for Medulloblastoma Progression. Clinical Cancer Research. 25(21). 6475–6486. 12 indexed citations

10.

Sementino, Eleonora, Yuwaraj Kadariya, Craig W. Menges, et al.. (2019). Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models. Cancer Research. 79(16). 4113–4123. 41 indexed citations

11.

Tang, Baiqing, et al.. (2018). Specific Targeting of MTAP -Deleted Tumors with a Combination of 2′-Fluoroadenine and 5′-Methylthioadenosine. Cancer Research. 78(15). 4386–4395. 26 indexed citations

12.

Nikonova, Anna S., Alexander Y. Deneka, Meghan C. Kopp, et al.. (2016). A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer. Clinical Cancer Research. 22(20). 5120–5129. 25 indexed citations

13.

Kadariya, Yuwaraj, Craig W. Menges, Jacqueline Talarchek, et al.. (2016). Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma. Cancer Prevention Research. 9(5). 406–414. 59 indexed citations

14.

Kadariya, Yuwaraj, Mitchell Cheung, Jinfei Xu, et al.. (2016). Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations. Cancer Research. 76(9). 2836–2844. 79 indexed citations

15.

Xu, Jinfei, Yuwaraj Kadariya, Mitchell Cheung, et al.. (2014). Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma. Cancer Research. 74(16). 4388–4397. 107 indexed citations

16.

Gumireddy, Kiranmai, Anping Li, Andrew V. Kossenkov, et al.. (2014). ID1 Promotes Breast Cancer Metastasis by S100A9 Regulation. Molecular Cancer Research. 12(9). 1334–1343. 35 indexed citations

17.

Mehra, Ranee, Fang Zhu, Dong‐Hua Yang, et al.. (2013). Quantification of Excision Repair Cross-Complementing Group 1 and Survival in p16-Negative Squamous Cell Head and Neck Cancers. Clinical Cancer Research. 19(23). 6633–6643. 21 indexed citations

18.

Seeger‐Nukpezah, Tamina, David A. Proia, Brian L. Egleston, et al.. (2013). Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease. Proceedings of the National Academy of Sciences. 110(31). 12786–12791. 37 indexed citations

19.

Chow, Hoi Yee, Adrian M. Jubb, Zahara M. Jaffer, et al.. (2012). p21-Activated Kinase 1 Is Required for Efficient Tumor Formation and Progression in a Ras-Mediated Skin Cancer Model. Cancer Research. 72(22). 5966–5975. 101 indexed citations

20.

Yang, Gong, Bin Chang, Fan Yang, et al.. (2010). Aurora Kinase A Promotes Ovarian Tumorigenesis through Dysregulation of the Cell Cycle and Suppression of BRCA2. Clinical Cancer Research. 16(12). 3171–3181. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact